Talk AI for Clinical Trials track
Gaining 70% Efficiencies by Using AI in Clinical Study Data Conformance
Wed, Feb 5, 2025 · 11:25–11:45 AM EST Rosen Shingle Creek
About this session
Pharma companies typically conduct exploratory analytics on legacy clinical studies (or trial data) to uncover insights that could inform current and future trial phases. Combining legacy studies is a process prone to friction—not only due to the sheer complexity of clinical data, but also because legacy studies come in disparate formats and can differ dramatically across therapeutic areas and study phases. With the use of AI, we developed a platform that has substantially reduced the time to conform, improved quality of data, and reduced the need for subject matter expertise.
